TriLink is an industry leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA. TriLink operates a robust and QSR 21 CFR 820 compliant quality system, and practices continual improvement of its quality standards. TriLink's product management, manufacturing and quality assurance teams work together to understand the challenges of each synthesis and develop, document and validate required processes and materials.
TriLink aims to exceed our customer's expectations by maintaining the highest level of quality and service.
All TriLink products undergo final analytical testing, typically a PAGE and MS analysis, to ensure the product meets our release specifications. The QC analyses are then incorporated in the certificate of analysis provided with each product. Every TriLink product and related documentation is reviewed by a Quality Assurance Specialist and verified to be correct before shipment.
Therapeutic GMP manufacturing available.